AstraZeneca’s vaccine has reached phase three clinical trials

4
605
Spread the love

AstraZeneca’s vaccine has reached phase three clinical trials
AstraZeneca’s vaccine has reached phase three clinical trials.Report says it shows potential immune response in the trials.
Astrazeneca or also called AZD1222 or ChAdOx1 nCoV-19.Developed by Oxford University.
India’s Serum Institute partnered with oxford university said it will price the shot at $3 per dose in india.


Spread the love

4 COMMENTS

  1. I am commenting to let you know of the fantastic encounter my cousin’s daughter experienced reading your site. She even learned many issues, not to mention what it’s like to have a wonderful giving mindset to have many people quite simply grasp chosen grueling subject areas. You really exceeded our expectations. Many thanks for giving the informative, healthy, educational and as well as easy thoughts on the topic to Jane.

LEAVE A REPLY

Please enter your comment!
Please enter your name here